Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.As of 26 May 2026, Alembic Pharma share price is ₹759.60. The stock opened at ₹762.30, compared to its previous close of ₹762.30. During today's trading session, Alembic Pharma share price moved in the range of ₹757.00 to ₹780.75, with an average price of ₹768.88 for the day. Looking at its last 52-week, the stock has touched a low of ₹757.00 and a high of ₹780.75.
The market capitalization of Alembic Pharma is ₹14,995 Crs, with a P/E ratio of 22.1 and a dividend yield of 1.57%.